Walter Stadler, MD FACP Dean for Clinical Research
Deputy Director Comprehensive Cancer Center University of Chicago discusses Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer
